Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 141


Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production.

Bissinger T, Fritsch J, Mihut A, Wu Y, Liu X, Genzel Y, Tan WS, Reichl U.

Vaccine. 2019 Apr 29. pii: S0264-410X(19)30528-6. doi: 10.1016/j.vaccine.2019.04.054. [Epub ahead of print]


Hydrophobic-interaction chromatography for purification of influenza A and B virus.

Weigel T, Soliman R, Wolff MW, Reichl U.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jun 1;1117:103-117. doi: 10.1016/j.jchromb.2019.03.037. Epub 2019 Apr 1.


Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.

Gränicher G, Coronel J, Pralow A, Marichal-Gallardo P, Wolff M, Rapp E, Karlas A, Sandig V, Genzel Y, Reichl U.

Vaccine. 2019 Apr 17. pii: S0264-410X(19)30481-5. doi: 10.1016/j.vaccine.2019.04.030. [Epub ahead of print]


Model-based analysis of influenza A virus replication in genetically engineered cell lines elucidates the impact of host cell factors on key kinetic parameters of virus growth.

Laske T, Bachmann M, Dostert M, Karlas A, Wirth D, Frensing T, Meyer TF, Hauser H, Reichl U.

PLoS Comput Biol. 2019 Apr 11;15(4):e1006944. doi: 10.1371/journal.pcbi.1006944. eCollection 2019 Apr.


A system for production of defective interfering particles in the absence of infectious influenza A virus.

Bdeir N, Arora P, Gärtner S, Hoffmann M, Reichl U, Pöhlmann S, Winkler M.

PLoS One. 2019 Mar 1;14(3):e0212757. doi: 10.1371/journal.pone.0212757. eCollection 2019.


High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.

Vázquez-Ramírez D, Jordan I, Sandig V, Genzel Y, Reichl U.

Appl Microbiol Biotechnol. 2019 Apr;103(7):3025-3035. doi: 10.1007/s00253-019-09694-2. Epub 2019 Feb 23.


Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions.

Rüdiger D, Kupke SY, Laske T, Zmora P, Reichl U.

PLoS Comput Biol. 2019 Feb 19;15(2):e1006819. doi: 10.1371/journal.pcbi.1006819. eCollection 2019 Feb.


RedCom: A strategy for reduced metabolic modeling of complex microbial communities and its application for analyzing experimental datasets from anaerobic digestion.

Koch S, Kohrs F, Lahmann P, Bissinger T, Wendschuh S, Benndorf D, Reichl U, Klamt S.

PLoS Comput Biol. 2019 Feb 1;15(2):e1006759. doi: 10.1371/journal.pcbi.1006759. eCollection 2019 Feb.


Improvement of electrospray stability in negative ion mode for nano-PGC-LC-MS glycoanalysis via post-column make-up flow.

Nguyen-Khuong T, Pralow A, Reichl U, Rapp E.

Glycoconj J. 2018 Dec;35(6):499-509. doi: 10.1007/s10719-018-9848-1. Epub 2018 Nov 23.


A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.

Kupke SY, Riedel D, Frensing T, Zmora P, Reichl U.

J Virol. 2019 Feb 5;93(4). pii: e01786-18. doi: 10.1128/JVI.01786-18. Print 2019 Feb 15.


The Fine Art of Destruction: A Guide to In-Depth Glycoproteomic Analyses-Exploiting the Diagnostic Potential of Fragment Ions.

Hoffmann M, Pioch M, Pralow A, Hennig R, Kottler R, Reichl U, Rapp E.

Proteomics. 2018 Dec;18(24):e1800282. doi: 10.1002/pmic.201800282.


glyXtoolMS: An Open-Source Pipeline for Semiautomated Analysis of Glycopeptide Mass Spectrometry Data.

Pioch M, Hoffmann M, Pralow A, Reichl U, Rapp E.

Anal Chem. 2018 Oct 16;90(20):11908-11916. doi: 10.1021/acs.analchem.8b02087. Epub 2018 Sep 25.


High-throughput Serum N-Glycomics: Method Comparison and Application to Study Rheumatoid Arthritis and Pregnancy-associated Changes.

Reiding KR, Bondt A, Hennig R, Gardner RA, O'Flaherty R, Trbojević-Akmačić I, Shubhakar A, Hazes JMW, Reichl U, Fernandes DL, Pučić-Baković M, Rapp E, Spencer DIR, Dolhain RJEM, Rudd PM, Lauc G, Wuhrer M.

Mol Cell Proteomics. 2019 Jan;18(1):3-15. doi: 10.1074/mcp.RA117.000454. Epub 2018 Sep 21.


Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production.

Nikolay A, Léon A, Schwamborn K, Genzel Y, Reichl U.

Appl Microbiol Biotechnol. 2018 Oct;102(20):8725-8737. doi: 10.1007/s00253-018-9275-z. Epub 2018 Aug 8.


Enzymatic Cascade Synthesis Provides Novel Linear Human Milk Oligosaccharides as Reference Standards for xCGE-LIF Based High-Throughput Analysis.

Fischöder T, Cajic S, Reichl U, Rapp E, Elling L.

Biotechnol J. 2019 Mar;14(3):e1800305. doi: 10.1002/biot.201800305. Epub 2018 Aug 23.


Establishment of a five-enzyme cell-free cascade for the synthesis of uridine diphosphate N-acetylglucosamine.

Mahour R, Klapproth J, Rexer TFT, Schildbach A, Klamt S, Pietzsch M, Rapp E, Reichl U.

J Biotechnol. 2018 Oct 10;283:120-129. doi: 10.1016/j.jbiotec.2018.07.027. Epub 2018 Jul 22.


Purification of influenza virus-like particles using sulfated cellulose membrane adsorbers.

B Carvalho S, Fortuna AR, Wolff MW, Peixoto C, M Alves P, Reichl U, Jt Carrondo M.

J Chem Technol Biotechnol. 2018 Jul;93(7):1988-1996. doi: 10.1002/jctb.5474. Epub 2017 Dec 16.


High-cell-density cultivations to increase MVA virus production.

Vázquez-Ramírez D, Genzel Y, Jordan I, Sandig V, Reichl U.

Vaccine. 2018 May 24;36(22):3124-3133. doi: 10.1016/j.vaccine.2017.10.112. Epub 2018 Feb 9.


MPA Portable: A Stand-Alone Software Package for Analyzing Metaproteome Samples on the Go.

Muth T, Kohrs F, Heyer R, Benndorf D, Rapp E, Reichl U, Martens L, Renard BY.

Anal Chem. 2018 Jan 2;90(1):685-689. doi: 10.1021/acs.analchem.7b03544. Epub 2017 Dec 19.


Cell culture-based production of defective interfering particles for influenza antiviral therapy.

Wasik MA, Eichwald L, Genzel Y, Reichl U.

Appl Microbiol Biotechnol. 2018 Feb;102(3):1167-1177. doi: 10.1007/s00253-017-8660-3. Epub 2017 Dec 5.

Supplemental Content

Loading ...
Support Center